Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Change in Cash: 2022-2024

Historic Change in Cash for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to -$8.3 million.

  • Orchestra BioMed Holdings' Change in Cash rose 1129.55% to $23.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.4 million, marking a year-over-year increase of 151.37%. This contributed to the annual value of -$8.3 million for FY2024, which is 177.01% down from last year.
  • As of FY2024, Orchestra BioMed Holdings' Change in Cash stood at -$8.3 million, which was down 177.01% from $10.8 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Change in Cash ranged from a high of $10.8 million in FY2023 and a low of -$8.3 million during FY2024.
  • Moreover, its 3-year median value for Change in Cash was $9.8 million (2022), whereas its average is $4.1 million.
  • Per our database at Business Quant, Orchestra BioMed Holdings' Change in Cash rose by 9.44% in 2023 and then tumbled by 177.01% in 2024.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Change in Cash stood at $9.8 million in 2022, then grew by 9.44% to $10.8 million in 2023, then tumbled by 177.01% to -$8.3 million in 2024.